Cargando…
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
Pharmacogenetics (PGx) has the potential to personalize pharmaceutical treatments. Many relevant gene–drug associations have been discovered, but PGx-guided treatment needs to be cost-effective as well as clinically beneficial to be incorporated into standard health-care. We reviewed economic evalua...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637230/ https://www.ncbi.nlm.nih.gov/pubmed/28607506 http://dx.doi.org/10.1038/tpj.2017.21 |